A detailed history of Joseph Group Capital Management transactions in Amgen Inc stock. As of the latest transaction made, Joseph Group Capital Management holds 8,633 shares of AMGN stock, worth $2.28 Million. This represents 1.2% of its overall portfolio holdings.

Number of Shares
8,633
Previous 7,464 15.66%
Holding current value
$2.28 Million
Previous $2.33 Million 19.25%
% of portfolio
1.2%
Previous 1.4%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$309.38 - $337.38 $361,665 - $394,397
1,169 Added 15.66%
8,633 $2.78 Million
Q2 2024

Aug 12, 2024

BUY
$262.75 - $319.31 $205,470 - $249,700
782 Added 11.7%
7,464 $2.33 Million
Q1 2024

May 13, 2024

BUY
$268.87 - $324.56 $1.76 Million - $2.12 Million
6,532 Added 4354.67%
6,682 $1.9 Million
Q4 2021

Feb 10, 2022

BUY
$198.88 - $227.6 $29,832 - $34,140
150 New
150 $34,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $141B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Joseph Group Capital Management Portfolio

Follow Joseph Group Capital Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Joseph Group Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Joseph Group Capital Management with notifications on news.